Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), bought 900,000 shares at $2.90 ($2.6M) on 2022-05-11, disclosed to the SEC on 2022-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.90 | 304,574 | $883K | 34.3% |
| 2 | $2.90 | 304,574 | $883K | 34.3% |
| 3 | $2.75 | 69,354 | $191K | 7.4% |
| 4 | $2.75 | 69,354 | $191K | 7.4% |
| 5 | $2.82 | 76,072 | $215K | 8.3% |
| 6 | $2.82 | 76,072 |
| $215K |
| 8.3% |
| Total | $2.86 avg | 900,000 | $2.6M | 100% |
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |